S&P 500
736.15
-4.00%
DOW
515.85
-3.24%
NASDAQ
652.05
-5.77%
Russell
271.91
-4.26%
VIX
22.82
+40.52%
FTSE
48.00
-1.90%
Nikkei
88.67
-5.53%
BTC
76,353.39
-4.64%
ETH
2,254.29
-6.64%
Gold
376.05
+0.96%
Oil
148.42
+2.07%
Silver
47.08
-0.17%
S&P 500
736.15
-4.00%
DOW
515.85
-3.24%
NASDAQ
652.05
-5.77%
Russell
271.91
-4.26%
VIX
22.82
+40.52%
FTSE
48.00
-1.90%
Nikkei
88.67
-5.53%
BTC
76,353.39
-4.64%
ETH
2,254.29
-6.64%
Gold
376.05
+0.96%
Oil
148.42
+2.07%
Silver
47.08
-0.17%
Stock
Ti
News
Markets
Stocks
Screener
Calendar
Watchlist
Loading...
Home
/
Stocks
/
XENE
/
News
XENE
NASDAQ · Biotechnology
Xenon Pharmaceuticals Inc
Mid-Cap Stocks
Biotech Stocks
Healthcare Stocks
$37.74
-1.45 (-3.70%)
☆ Watch
As of Nov 5, 8:35 PM ET ·
Overview
Earnings
Forecast
Financials
News
Peers
Technicals
XENE News
1 articles
Xenon Pharma Stock Plunges 31% on Psychiatry Trial Halt
Xenon Pharmaceuticals shares tumbled 30.7% after pausing enrollment in depression studies due to neuropsychiatric adverse events, overshadowing its FDA filing for azetukalner in epilepsy.
Analysis
Sep 18
↑